HU900916D0 - Treatment of sicknesses caused by the lack of iodine - Google Patents
Treatment of sicknesses caused by the lack of iodineInfo
- Publication number
- HU900916D0 HU900916D0 HU90916A HU91690A HU900916D0 HU 900916 D0 HU900916 D0 HU 900916D0 HU 90916 A HU90916 A HU 90916A HU 91690 A HU91690 A HU 91690A HU 900916 D0 HU900916 D0 HU 900916D0
- Authority
- HU
- Hungary
- Prior art keywords
- iodine
- treatment
- composition
- lack
- breast cancer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/18—Iodine; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Developing Agents For Electrophotography (AREA)
Abstract
This invention relates to a composition for use in the treatment of iodine deficiency diseases such as fibrocystic dysplasia breast cancer, endometriosis and premenstrual syndrome. The composition may also be used for the prophylaxis of breast cancer. More particularly, this invention relates to a composition for the treatment of iodine deficiency diseases, the composition comprising a solution of elemental iodine (I2) which may also be referred to as metallic iodine or iodine metal. The elemental iodine is soluble in water which leaves it thermodynamically free. The term "aqueous iodine" may also be used to refer to such an aqueous solution.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/292,968 US5171582A (en) | 1985-07-31 | 1989-01-03 | Treatment of iodine deficiency diseases |
Publications (2)
Publication Number | Publication Date |
---|---|
HU900916D0 true HU900916D0 (en) | 1991-10-28 |
HUT57050A HUT57050A (en) | 1991-11-28 |
Family
ID=23127029
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU90916A HUT57050A (en) | 1989-01-03 | 1990-01-03 | Process for treating diseases with lake of iodine |
Country Status (14)
Country | Link |
---|---|
US (1) | US5171582A (en) |
EP (1) | EP0377266B1 (en) |
JP (1) | JP2994741B2 (en) |
AT (1) | ATE106738T1 (en) |
AU (1) | AU639222B2 (en) |
BG (1) | BG94738A (en) |
BR (1) | BR9006990A (en) |
CA (1) | CA1336889C (en) |
DE (1) | DE68915987T2 (en) |
DK (1) | DK128291A (en) |
ES (1) | ES2057098T3 (en) |
HU (1) | HUT57050A (en) |
MC (1) | MC2172A1 (en) |
WO (1) | WO1990007339A1 (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5250304A (en) * | 1985-07-31 | 1993-10-05 | Ghent William R | Treatment of iodine deficiency diseases |
US5589198A (en) * | 1985-07-31 | 1996-12-31 | 943038 Ontario, Inc. | Treatment of iodine deficiency diseases |
US6019970A (en) * | 1985-07-31 | 2000-02-01 | Ghent William R. | Treatment of iodine deficiency diseases |
US5955101A (en) * | 1991-03-28 | 1999-09-21 | 943038 Ontario Inc. | Dry starch-iodine pharmaceutical formulations |
US5910318A (en) * | 1991-03-28 | 1999-06-08 | 943038 Ontario Inc. | Treatment of iodine deficiency diseases |
WO1992017190A1 (en) * | 1991-03-28 | 1992-10-15 | Ghent William R | Dry starch-iodine pharmaceutical formulations |
EP0722727A1 (en) * | 1995-01-20 | 1996-07-24 | Eli Lilly And Company | Benzofuran derivatives for inhibiting uterine fibroid disease |
US5489587A (en) * | 1995-01-20 | 1996-02-06 | Eli Lilly And Company | Benzofurans used to inhibit bone loss |
US5554600A (en) * | 1995-01-20 | 1996-09-10 | Eli Lilly And Company | Methods for inhibiting endometriosis |
US6238644B1 (en) | 1997-09-03 | 2001-05-29 | Wayne State University | Method for treating and/or imaging breast cancer using radioactive iodide |
US5885592A (en) * | 1997-10-29 | 1999-03-23 | Symbollon Corporation | Methods and pharmaceutical compositions for oral delivery of molecular iodine |
US20090214434A1 (en) * | 2004-08-20 | 2009-08-27 | O'dowd Dennis Hardy | Method of detecting and treating allogenic cells responsible for endometriosis |
US9511151B2 (en) | 2010-11-12 | 2016-12-06 | Uti Limited Partnership | Compositions and methods for the prevention and treatment of cancer |
US10988516B2 (en) | 2012-03-26 | 2021-04-27 | Uti Limited Partnership | Methods and compositions for treating inflammation |
US9603948B2 (en) | 2012-10-11 | 2017-03-28 | Uti Limited Partnership | Methods and compositions for treating multiple sclerosis and related disorders |
EP3065771B1 (en) | 2013-11-04 | 2019-03-20 | UTI Limited Partnership | Methods and compositions for sustained immunotherapy |
JP6920211B2 (en) | 2015-05-06 | 2021-08-18 | ユーティーアイ リミテッド パートナーシップ | Nanoparticle composition for sustained therapy |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4384960A (en) * | 1979-11-13 | 1983-05-24 | Polley R D | Iodine dispenser and method of dispensing iodine |
US4816255A (en) * | 1985-07-31 | 1989-03-28 | Ghent William R | Treatment of iodine deficiency breast syndrome |
FR2611733B1 (en) * | 1987-02-26 | 1989-06-16 | Rhone Poulenc Chimie | IODINE-CONTAINING DIORGANOPOLYSILOXANE GUM COMPOSITION FOR WATER TREATMENT |
-
1989
- 1989-01-03 US US07/292,968 patent/US5171582A/en not_active Expired - Lifetime
- 1989-01-09 CA CA000587744A patent/CA1336889C/en not_active Expired - Fee Related
- 1989-01-10 ES ES89300194T patent/ES2057098T3/en not_active Expired - Lifetime
- 1989-01-10 DE DE68915987T patent/DE68915987T2/en not_active Expired - Fee Related
- 1989-01-10 AT AT89300194T patent/ATE106738T1/en not_active IP Right Cessation
- 1989-01-10 EP EP89300194A patent/EP0377266B1/en not_active Expired - Lifetime
-
1990
- 1990-01-03 BR BR909006990A patent/BR9006990A/en not_active Application Discontinuation
- 1990-01-03 JP JP2501437A patent/JP2994741B2/en not_active Expired - Fee Related
- 1990-01-03 AU AU48199/90A patent/AU639222B2/en not_active Ceased
- 1990-01-03 MC MC90@@D patent/MC2172A1/en unknown
- 1990-01-03 WO PCT/CA1990/000007 patent/WO1990007339A1/en active Application Filing
- 1990-01-03 HU HU90916A patent/HUT57050A/en unknown
-
1991
- 1991-07-01 DK DK128291A patent/DK128291A/en not_active Application Discontinuation
- 1991-07-02 BG BG094738A patent/BG94738A/en unknown
Also Published As
Publication number | Publication date |
---|---|
DE68915987T2 (en) | 1995-01-12 |
ATE106738T1 (en) | 1994-06-15 |
BG94738A (en) | 1993-12-24 |
AU639222B2 (en) | 1993-07-22 |
EP0377266A1 (en) | 1990-07-11 |
ES2057098T3 (en) | 1994-10-16 |
BR9006990A (en) | 1991-11-12 |
AU4819990A (en) | 1990-08-01 |
DK128291A (en) | 1991-08-21 |
EP0377266B1 (en) | 1994-06-08 |
CA1336889C (en) | 1995-09-05 |
MC2172A1 (en) | 1992-05-22 |
DE68915987D1 (en) | 1994-07-14 |
JPH04503949A (en) | 1992-07-16 |
WO1990007339A1 (en) | 1990-07-12 |
US5171582A (en) | 1992-12-15 |
JP2994741B2 (en) | 1999-12-27 |
DK128291D0 (en) | 1991-07-01 |
HUT57050A (en) | 1991-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HU900916D0 (en) | Treatment of sicknesses caused by the lack of iodine | |
NZ224231A (en) | Gels containing metal chlorite as disinfectant | |
UA39158C2 (en) | derivatives of N4-oxycarbonyl- 5'-deoxy-5-fluorocytidine and pharmaceutical preparation based thereon | |
ES2060883T3 (en) | PROCEDURE FOR OBTAINING CARNOSIC ACID. | |
GR3005528T3 (en) | ||
DE3267352D1 (en) | Novel aroylimidazolones | |
IT8547596A0 (en) | CHELATING COMPOUNDS FOR THE REDUCTION OF METAL IONS CONTAINED IN BODY TISSUES, PARTICULARLY IRON, PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH COMPOUNDS AND PREPARATION PROCEDURE | |
SE8005580L (en) | HARVEXT COMPOSITION AND PROCEDURE FOR ITS MANUFACTURING | |
FR2442250A1 (en) | GLASS COMPOSITIONS AND CEMENTS IN WHICH THESE COMPOSITIONS ARE INCORPORATED | |
ES8304919A1 (en) | Dichloroamino acid derivatives useful as potent germicidal and fungicidal agents. | |
FR2651435B1 (en) | ||
GR3025120T3 (en) | Alkaloids from mappia foetida, the use thereof and formulations containing them. | |
HK1005454A1 (en) | Pure crystalline form of refapentine | |
RO79426B1 (en) | Medicinal composition for treating neuroviroses | |
NO912528L (en) | TREATMENT OF DISEASES CONNECTED WITH IOD Deficiency. | |
IL70649A0 (en) | Triazine derivative,its preparation and its use as herbicide | |
DE69012687D1 (en) | Metal protective compositions, their manufacturing process and metal protection process. | |
JPS53142315A (en) | Manufacture of cu-ni-sn alloy material | |
WO2003030884A3 (en) | Use of solasonine for the treatment of skin tumors | |
GB8800357D0 (en) | Teat treating compositions production & use thereof | |
OTA | Corrosion of Iron in Concentrated Alkaline Solution | |
PT74513A (en) | Process for the preparation of metal complexes of ethylene-1,2-bis-dithiocarbamic acid and 8-hydroxychinolin and of fungicidal and bactericidal compositions containing them | |
ES8507140A1 (en) | Citric-acid salt of (-)vinburnine and process for its preparation. | |
MD421C2 (en) | Aminoacids derivatives and the acid additive salts thereof | |
PT99146A (en) | Process for the preparation of inclusion complexes with silibinine and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DFC9 | Refusal of application |